Cite
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.
MLA
Ballou, Sarah, et al. “Open-Label versus Double-Blind Placebo Treatment in Irritable Bowel Syndrome: Study Protocol for a Randomized Controlled Trial.” Trials, vol. 18, May 2017, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13063-017-1964-x.
APA
Ballou, S., Kaptchuk, T. J., Hirsch, W., Nee, J., Iturrino, J., Hall, K. T., Kelley, J. M., Vivian Cheng, Kirsch, I., Jacobson, E., Conboy, L., Lembo, A., Davis, R. B., & Cheng, V. (2017). Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials, 18, 1–15. https://doi.org/10.1186/s13063-017-1964-x
Chicago
Ballou, Sarah, Ted J. Kaptchuk, William Hirsch, Judy Nee, Johanna Iturrino, Kathryn T. Hall, John M. Kelley, et al. 2017. “Open-Label versus Double-Blind Placebo Treatment in Irritable Bowel Syndrome: Study Protocol for a Randomized Controlled Trial.” Trials 18 (May): 1–15. doi:10.1186/s13063-017-1964-x.